What is 32 Bio Sciences?
32 Bio Sciences is at the forefront of microbiome medicine, developing precision diagnostics and therapeutics aimed at revolutionizing healthcare. The company's core mission involves defining, diagnosing, and restoring the functional health of the gut microbiome. By addressing chronic diseases at their root, 32 Bio Sciences seeks to enhance health span and promote longevity through innovative biotechnological solutions.
How much funding has 32 Bio Sciences raised?
32 Bio Sciences has raised a total of $6M across 1 funding round:
Other Financing Round
$6M
Other Financing Round (2025): $6M, investors not publicly disclosed
What's next for 32 Bio Sciences?
The recent major strategic investment signals a new phase of accelerated growth and development for 32 Bio Sciences. This capital infusion is expected to fuel the expansion of its diagnostic capabilities and the advancement of its therapeutic pipeline. The company is poised to further solidify its position in the burgeoning field of microbiome research, potentially leading to significant breakthroughs in the prevention and treatment of a wide range of chronic conditions.
See full 32 Bio Sciences company page
